Immungenetics

Immungenetics AG is a clinical-stage biopharmaceutical company developing effective treatments for debilitating diseases associated with aging, targeting two major therapeutic areas as well as orphan/rare indications. Current programs encompass neurodegeneration, mitochondrial dysfunction, metabolic syndrome, autoimmune diseases, inflammation, and lifespan.Headquartered in Rostock, Germany, with laboratories in Lubeck and Oslo, the company has created three patented drug discovery and development platforms to deliver first-in-class therapies based on novel mechanisms of action.